5-DBCO-PEG4-dCpG
|
|
|
5-Propargylamino-CTP - DYQ-660
|
|
|
5-Propargylamino-dCTP - 5/6-TAMRA
|
|
|
EDA-m7GTP - ATTO-590
|
|
|
2-Deoxy-2-fluoroarabinocytidine-3-CE-phosphoramidite
|
|
|
5-Propargylamino-ddCTP - ATTO-Thio12
|
|
|
7-Propargylamino-7-deaza-ddATP - 6-FAM
|
|
|
7-Propargylamino-7-deaza-dGTP - ATTO-612Q
|
|
|
8-[(6-Amino)hexyl]-amino-cGMP - Cy3
|
|
|
8-Bromo-GMP
|
|
|
Aminoallyl-dUTP - ATTO-594
|
|
|
8-AET-c-diGMP-Agarose
|
|
|
EDA-ADP - ATTO-655
|
|
|
4-Thio-UDP
|
|
|
7-Propargylamino-7-deaza-dATP - DYQ-660
|
|
|
7-Propargylamino-7-deaza-ddATP - ATTO-633
|
|
|
8-[(6-Amino)hexyl]-amino-ATP - Cy5
|
|
|
8-[(6-Amino)hexyl]-amino-cAMP - ATTO-Rho13
|
|
|
8-[(6-Amino)hexyl]-amino-GMP - ATTO-655
|
|
|
8-[(6-Amino)hexyl]-amino-GMP - DY-480XL
|
|
|
Aminoallyl-dUTP-XX-Cy3
|
|
|
N6-(6-Amino)hexyl-dATP - ATTO-540Q
|
|
|
8-[(6-Amino)hexyl]-amino-ATP - ATTO-700
|
|
|
Aminoallyl-dUTP - ATTO-612Q
|
|
|
Sp-2-CF3-cBIMPS
|
|
|
EDA-m7GDP - ATTO-532
|
|
|
Cytidine (N-Bz)
|
|
|
5-Propargylamino-CTP - ATTO-590
|
|
|
5-Propargylamino-ddCTP - ATTO-655
|
|
|
5-Propargylamino-ddUTP - 5/6-TAMRA
|
|
|
N6-(6-Amino)hexyl-ATP - ATTO-612Q
|
|
|
N6-(6-Amino)hexyl-dATP - ATTO-465
|
|
|
N6-(6-Amino)hexyl-dATP - ATTO-550
|
|
|
γ-[(6-Aminohexyl)-imido]-GTP
|
|
|
EDA-GTPγS - ATTO-580Q
|
|
|
7-Propargylamino-7-deaza-ddATP - DY-751
|
|
|
N6-(6-Amino)hexyl-ATP - Cy3
|
|
|
N6-(6-Amino)hexyl-dATP - 6-ROX
|
|
|
N6-(6-Amino)hexyl-dATP - ATTO-700
|
|
|
EDA-AppNHp (EDA-AMPPNP) - DY-751
|
|
|
5-Azido-PEG4-UTP
|
|
|
5-Propargylamino-CTP - ATTO-633
|
|
|
5-Propargylamino-CTP - ATTO-700
|
|
|
5-Propargylamino-dCTP - ATTO-565
|
|
|
8-[(6-Amino)hexyl]-amino-ATP - DYQ-660
|
|
|
8-[(6-Amino)hexyl]-amino-GMP - ATTO-MB2
|
|
|
8-[(6-Amino)hexyl]-amino-GTP - ATTO-680
|
|
|
N6-(6-Amino)hexyl-ATP - DYQ-661
|
|
|
EDA-GTP - ATTO-Rho12
|
|
|
EDA-GTPγS - ATTO-488
|
|
|
2-Chloro-N6-iso-pentenyladenosine
|
|
|
3'-beta-C-Methyl-5-methoxyuridine
|
|
|
3'-beta-C-Methyl-N6-(m-trifluoromethylbenzyl)adenosine
|
|
|
N6-(6-Amino)hexyl-ATP - DY-751
|
|
|
3'-Deoxy-3'-fluoro-xylo-N6-(p-methoxybenzyl)adenosine
|
|
|
Blood group B type 1 tetrasaccharide-NGL
|
|
|
5-Propargylamino-ddUTP - ATTO-Thio12
|
|
|
7-Propargylamino-7-deaza-ddGTP - ATTO-Rho12
|
|
|
Aminoallyl-dUTP - ATTO-Rho101
|
|
|
N6-(6-Azido)hexyl-ATP
|
|
|
γ-(6-Aminohexyl)-GTP - ATTO-Rho13
|
|
|
Sp-8-BnT-cAMPS / "S-220"
|
|
|
EDA-m7GTP - ATTO-MB2
|
|
|
7-Propargylamino-7-deaza-ddATP - 6-ROX
|
|
|
7-Propargylamino-7-deaza-dATP - ATTO-Rho13
|
|
|
5-Propargylamino-ddUTP - ATTO-495
|
|
|
5-Propargylamino-ddCTP - ATTO-Rho13
|
|
|
EDA-m7GDP - DY-751
|
|
|
8-[(6-Amino)hexyl]-amino-GMP - ATTO-565
|
|
|
8-[(6-Amino)hexyl]-amino-cGMP - OYSTER-656
|
|
|
8-[(6-Amino)hexyl]-amino-cAMP - MANT
|
|
|
8-[(6-Amino)hexyl]-amino-ATP - MANT
|
|
|
8-[(6-Amino)hexyl]-amino-ATP - 6-FAM
|
|
|
Man-9 Glycan, 2-AA labelled
|
|
|
Blood group A-BSA (6 atom spacer)
|
|
|
EDA-GTP
|
|
|
EDA-AppNHp (EDA-AMPPNP) - ATTO-Rho101
|
|
|
Aminoallyl-UTP - ATTO-Rho12
|
|
|
Blood group B type 2 tetrasaccharide-NGL
|
|
|
γ-(6-Aminohexyl)-ATP - 6-JOE
|
|
|
m7G(5')ppp(5')(2'OMeA)pU
|
|
|
N6-(6-Amino)hexyl-dATP - DY-776
|
|
|
5'-O-(4,4'-Dimethoxytrityl)-2'-O-methyl-5-iodouridine-3'-O-[(2-cyanoethyl)-(N,N-diisopropyl)]phosphoramidite
|
|
|
EDA-m7GTP - ATTO-580Q
|
|
|
6-cPe-ATP-γ-S
|
|
|
5-Propargylamino-ddCTP - ATTO-620
|
|
|
FA2BG1 Glycan, 2-AA labelled
|
|
|
7-Propargylamino-7-deaza-ddGTP - ATTO-655
|
|
|
5-Propargylamino-ddUTP - DYQ-660
|
|
|
EDA-GTPγS - ATTO-655
|
|
|
EDA-ATP - ATTO-Rho13
|
|
|
EDA-AppNHp (EDA-AMPPNP) - DY-480XL
|
|
|
6-cHe-ADP
|
|
|
7-Propargylamino-7-deaza-dATP - ATTO-550
|
|
|
5-Propargylamino-CTP - ATTO-580Q
|
|
|
2,6-Bis(4-morpholinyl)-9-b-D-ribofuranosyl-9H-purine
|
|
|
8-[(6-Amino)hexyl]-amino-cGMP - ATTO-Rho6G
|
|
|
8-[(6-Amino)hexyl]-amino-cGMP - ATTO-550
|
|
|
8-[(6-Amino)hexyl]-amino-cAMP - DYQ-661
|
|
|
8-[(6-Amino)hexyl]-amino-cAMP - DY-480XL
|
|
|